期刊文献+

肝脏瞬时弹性超声评价自身免疫性肝炎肝纤维化的价值 被引量:16

Vafidation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmone hepatitis
原文传递
导出
摘要 目的验证肝脏瞬时弹性超声在评估自身免疫性肝炎(AIH)患者肝纤维化程度中的价值。方法用瞬时弹性超声对30例AIH患者进行肝脏瞬时弹性测定,并将测定值与按照Scheuer系统进行纤维化分级的患者肝活组织检查结果作纤维化程度的比较,用Spearman等级相关系数方法进行统计学分析。结果30例AIH患者中S0期4例,S1期6例,S2期5例,S3期11例,s4期4例。除1例患者因肥胖导致瞬时弹性超声检测失败以外,其余均顺利受检。29例患者测定的瞬时弹性超声硬度值与其肝纤维化分期有显著相关性(r=0.801,P〈0.01)。将S0、s1、S2期合并与S3、s4期合并后对两组间瞬时弹性超声硬度值作比较,t=-3.937,P=0.001,差异有统计学意义。结论肝脏瞬时弹性超声评估AIH患者肝纤维化程度的可靠性较好,并且由于其无创性而在此类患者的长期随访与疗效评估中有着较好的应用前景。 Objective To validate transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis (AIH). Methods Liver stiffness was assessed using Fibroscan in totally 30 patients with AIH. We compared the results of Fibroscan with the Scheuer fibrosis stage in liver biopsy in each patient. Results 4 patients were shown as liver fibrosis stage SO, 6 as S1,5 as S2, 11 as S3 and 4 as S4. Failure of the Fibroscan measurement occurred in 1 case (3.3%) because of her increased body mass index (BMI). The stiffness of Fibros can was significantly correlated with the liver biopsy fibrosis stage (r= 0.801, P〈 0.001). The liver stiffnesses between mild and moderate fibrosis (S0-2) and advanced fibrosis (S3-4) were significantly different (t=-3.937, P=0.001). Conclusion Transient elastography (Fibroscan) is a promising non-invasive method for detection of fibrosis in patients with autoimmune hepatitis. Its use for the follow up and management of these patients and should be evaluated further.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2011年第10期782-784,共3页 Chinese Journal of Hepatology
基金 国家自然科学基金(30972751) 上海交通大学医学院附属仁济医院科研培育基金(RJPY10-002) 2010年上海高校选拔培养优秀青年教师科研专项基金(沪教委人【2010]83号)
关键词 肝硬化 肝炎 自身免疫性 超声检查 Liver cirrhosis Hepatitis, autoimmune Ultrasonography
  • 相关文献

参考文献7

  • 1Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 1991, 13: 372-374.
  • 2Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmtme Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31 : 929-938.
  • 3Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 2001, 357: 1069-1075.
  • 4Fores X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.Hepatology, 2002, 36: 986-992.
  • 5Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38:518-526.
  • 6Bissell DM. Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology, 2004, 127: 1847-1849.
  • 7Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol, 2007, 46: 628-634.

同被引文献127

引证文献16

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部